Idarubicin (BioDeep_00000405862)

   

Chemicals and Drugs Antibiotics


代谢物信息卡片


Idarubicin

化学式: C26H27NO9 (497.1685732000001)
中文名称: 依达比星
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
InChI: InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1

描述信息

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
D004791 - Enzyme Inhibitors

同义名列表

1 个代谢物同义名

Idarubicin



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Jie Ding, Yang Su, Yinglu Ruan, Nan Li, Qianchao Meng, Jiabang Yang, Li Chen, Chi Liu. Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China. Hematology (Amsterdam, Netherlands). 2024 Dec; 29(1):2310960. doi: 10.1080/16078454.2024.2310960. [PMID: 38323781]
  • Mohammad Mehmandoust, Pouran Pourhakkak, Gizem Tiris, Hassan Karimi-Maleh, Nevin Erk. A reusable and sensitive electrochemical sensor for determination of idarubicin in environmental and biological samples based on NiFe2O4 nanospheres anchored N-doped graphene quantum dots composite; an electrochemical and molecular docking investigation. Environmental research. 2022 Sep; 212(Pt B):113264. doi: 10.1016/j.envres.2022.113264. [PMID: 35427589]
  • Dorota Matyszewska, Ewa Nazaruk, Richard A Campbell. Interactions of anticancer drugs doxorubicin and idarubicin with lipid monolayers: New insight into the composition, structure and morphology. Journal of colloid and interface science. 2021 Jan; 581(Pt A):403-416. doi: 10.1016/j.jcis.2020.07.092. [PMID: 32771749]
  • Colin P Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan Madanat, Prapti Patel, Madhuri Vusirkala, Praveen Ramakrishnan, Syed Rizvi, Stephen Chung, Farrukh Awan, Larry D Anderson, Robert Collins, Ankit Kansagra. The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement. Leukemia research. 2021 01; 100(?):106480. doi: 10.1016/j.leukres.2020.106480. [PMID: 33285315]
  • Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, Joseph A Ippolito, Chun-Hui Zhang, Israel Cabeza de Vaca, Maria-Elena Liosi, Karen S Anderson, William L Jorgensen. Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2. ACS medicinal chemistry letters. 2020 Dec; 11(12):2526-2533. doi: 10.1021/acsmedchemlett.0c00521. [PMID: 33324471]
  • Olga Maliszewska, Natalia Treder, IIona Olędzka, Piotr Kowalski, Natalia Miękus, Tomasz Bączek, Wojciech Rodzaj, Ewa Bień, Małgorzata Anna Krawczyk, Alina Plenis. Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring. Molecules (Basel, Switzerland). 2020 Dec; 25(24):. doi: 10.3390/molecules25245799. [PMID: 33316898]
  • Balasubramani Gl, Rinky Rajput, Manish Gupta, Pradeep Dahiya, Jitendra K Thakur, Rakesh Bhatnagar, Abhinav Grover. Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis. The Biochemical journal. 2020 11; 477(21):4167-4190. doi: 10.1042/bcj20200462. [PMID: 33030198]
  • Xinping Zhou, Chen Mei, Jin Zhang, Ying Lu, Jianping Lan, Shengyun Lin, Yuefeng Zhang, Yuemin Kuang, Yanling Ren, Liya Ma, Juying Wei, Li Ye, Weilai Xu, Kongfei Li, Chenxi Lu, Jie Jin, Hongyan Tong. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial. Hematological oncology. 2020 Oct; 38(4):531-540. doi: 10.1002/hon.2755. [PMID: 32469434]
  • Brendan O'Kelly, Padraig McGettrick, Daniel Angelov, Michael Fay, Tara McGinty, Aoife G Cotter, Gerard Sheehan, John S Lambert. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2. British journal of haematology. 2020 Jul; 190(1):e1-e3. doi: 10.1111/bjh.16798. [PMID: 32379903]
  • Pengfei She, Shijia Li, Linying Zhou, Zhen Luo, Jinfeng Liao, Lanlan Xu, Xianghai Zeng, Ti Chen, Yaqian Liu, Yong Wu. Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus. Virulence. 2020 01; 11(1):636-651. doi: 10.1080/21505594.2020.1770493. [PMID: 32423280]
  • Ke Li, Feng Wang, Zhao-Na Yang, Bing Cui, Ping-Ping Li, Zhen-Yu Li, Zhuo-Wei Hu, Hong-Hu Zhu. PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia. Theranostics. 2020; 10(22):10326-10340. doi: 10.7150/thno.45924. [PMID: 32929351]
  • D Amicizia, R T Micale, B M Pennati, F Zangrillo, M Iovine, E Lecini, F Marchini, P L Lai, D Panatto. Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas. Journal of preventive medicine and hygiene. 2019 Dec; 60(4):E271-E285. doi: 10.15167/2421-4248/jpmh2019.60.4.1333. [PMID: 31967084]
  • Bin Liang, Na Li, Shuofei Zhang, Aihua Qi, Jianhua Feng, Weiwei Jing, Changcan Shi, Zhaipu Ma, Shenmeng Gao. Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(l-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity. International journal of nanomedicine. 2019; 14(?):543-556. doi: 10.2147/ijn.s190027. [PMID: 30666113]
  • Sabry M Attia, Ali Y Alshahrani, Mohammed A Al-Hamamah, Mohammed M Attia, Quaiser Saquib, Sheikh F Ahmad, Mushtaq A Ansari, Ahmed Nadeem, Saleh A Bakheet. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice. Toxicological sciences : an official journal of the Society of Toxicology. 2017 Nov; 160(1):161-172. doi: 10.1093/toxsci/kfx161. [PMID: 28973540]
  • Charlotte K Brierley, Toby A Eyre. Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration. Blood. 2017 06; 129(25):3396. doi: 10.1182/blood-2017-03-765776. [PMID: 28642361]
  • Madita Uffmann, Mareike Rasche, Martin Zimmermann, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Lenie Scheffers, Henrik Hasle, C Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann. Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. Blood. 2017 06; 129(25):3314-3321. doi: 10.1182/blood-2017-01-765057. [PMID: 28400376]
  • Kim Timmermans, Guus P Leijte, Matthijs Kox, Gert Jan Scheffer, Nicole M A Blijlevens, Peter P Pickkers. Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients. Acta haematologica. 2017; 138(1):39-43. doi: 10.1159/000477530. [PMID: 28723682]
  • Joanna Laskowska, Joanna Lewandowska-Bieniek, Joanna Szczepanek, Jan Styczyński, Andrzej Tretyn. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias. The journal of gene medicine. 2016 Aug; 18(8):165-79. doi: 10.1002/jgm.2889. [PMID: 27280600]
  • Melanie Adler, Susanne Ramm, Marc Hafner, Jeremy L Muhlich, Esther Maria Gottwald, Elijah Weber, Alenka Jaklic, Amrendra Kumar Ajay, Daniel Svoboda, Scott Auerbach, Edward J Kelly, Jonathan Himmelfarb, Vishal S Vaidya. A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. Journal of the American Society of Nephrology : JASN. 2016 Apr; 27(4):1015-28. doi: 10.1681/asn.2015010060. [PMID: 26260164]
  • Linda Koutova, Monika Sterbova, Eva Pazourkova, Sarka Pospisilova, Iveta Svobodova, Ales Horinek, Daniel Lysak, Marie Korabecna. The impact of standard chemotherapy on miRNA signature in plasma in AML patients. Leukemia research. 2015 Dec; 39(12):1389-95. doi: 10.1016/j.leukres.2015.08.009. [PMID: 26340914]
  • Trinity Vera, Ralph B D'Agostino, Jennifer H Jordan, Matthew C Whitlock, Giselle C Meléndez, Zanetta S Lamar, Mercedes Porosnicu, Herbert L Bonkovsky, Leslie B Poole, W Gregory Hundley. Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy. The American journal of cardiology. 2015 Dec; 116(11):1752-5. doi: 10.1016/j.amjcard.2015.08.042. [PMID: 26433273]
  • José Carlos Jaime-Pérez, Xitlaly Judith González-Leal, Mónica Andrea Pinzón-Uresti, Andrés Gómez-De León, Olga G Cantú-Rodríguez, Homero Gutiérrez-Aguirre, David Gómez-Almaguer. Is There Still a Role for Low-Dose All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia in the Arsenic Trioxide Era?. Clinical lymphoma, myeloma & leukemia. 2015 Dec; 15(12):816-9. doi: 10.1016/j.clml.2015.09.002. [PMID: 26500134]
  • Y Z Su, C B Wang, Y Zhou, N T Sun. Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients. Genetics and molecular research : GMR. 2015 May; 14(2):5181-7. doi: 10.4238/2015.may.18.8. [PMID: 26125711]
  • A Estella-Hermoso de Mendoza, R Castello-Cros, E Imbuluzqueta, C Cirauqui, R Pippa, M D Odero, M J Blanco-Prieto. Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia. Journal of biomedical nanotechnology. 2015 Apr; 11(4):691-701. doi: 10.1166/jbn.2015.1944. [PMID: 26310075]
  • Chia-Wen Hsu, Jinghua Zhao, Ruili Huang, Jui-Hua Hsieh, Jon Hamm, Xiaoqing Chang, Keith Houck, Menghang Xia. Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Scientific reports. 2014 Sep; 4(?):6437. doi: 10.1038/srep06437. [PMID: 25257666]
  • Julia Riganti, Mariana P Caviedes, Ana C Torre, Mariana Guzzi Maqueda, Maria C Baztan Piñero, Victoria I Volonteri, Ricardo L Galimberti. Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemia. International journal of dermatology. 2014 Jul; 53(7):912-6. doi: 10.1111/ijd.12316. [PMID: 24602108]
  • Mathieu Boulin, Héloïse Adam, Boris Guiu, Ludwig Serge Aho, Jean-Pierre Cercueil, Cyrille Di Martino, Philippe Fagnoni, Anne Minello, Jean Louis Jouve, Patrick Hillon, Laurent Bedenne, Côme Lepage. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2014 Apr; 46(4):358-62. doi: 10.1016/j.dld.2013.12.012. [PMID: 24462550]
  • Dean Smith, Jane Stevens, John Quinn, Jamie Cavenagh, Wendy Ingram, Kwee Yong. Myeloma presenting during pregnancy. Hematological oncology. 2014 Mar; 32(1):52-5. doi: 10.1002/hon.2088. [PMID: 23996410]
  • Gianluca Villa, Jose J Zaragoza, Aashish Sharma, Cosimo Chelazzi, Claudio Ronco, A Raffaele De Gaudio. High cutoff membrane to reduce systemic inflammation due to differentiation syndrome: a case report. Blood purification. 2014; 38(3-4):234-8. doi: 10.1159/000369379. [PMID: 25531172]
  • Liang Guo, Luke Coyle, Rory M C Abrams, Raymond Kemper, Eric T Chiao, Kyle L Kolaja. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicological sciences : an official journal of the Society of Toxicology. 2013 Dec; 136(2):581-94. doi: 10.1093/toxsci/kft205. [PMID: 24052561]
  • Manuel Polaina-Rusillo, Maria del Pilar Pérez-del Barrio, Ana Maria Carrillo-Colmenero, César Ramírez-Tortosa, Josefa Borrego-Hinojosa, Antonio Liébana-Cañada. Renal cortical necrosis secondary to thrombotic microangiopathy in the context of acute promyelocytic leukaemia blast crisis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2013 Nov; 33(6):845-8. doi: 10.3265/nefrologia.pre2013.sep.12162. [PMID: 24241370]
  • Ren-zhi Pei, Shuang-yue Li, Pei-sheng Zhang, Jun-xia Ma, Xu-hui Liu, Xiao-hong Du, Dong Chen, Ke-ya Sha, Lie-guang Chen, Jun-jie Cao, Xian-xu Zhuang, Jing-yi Wu, Li Lin, Zheng Fan, Pei-pei Ye, Shan-hao Tang, Bi-bo Zhang, Xiao-wei Shi. [Clinical investigation of homoharringtonine in combination with all-transretinoic acid and arsenic trioxide for acute promyelocytic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2013 Feb; 34(2):144-8. doi: NULL. [PMID: 23611222]
  • Amir T Fathi, Hossein Sadrzadeh, Darrell R Borger, Karen K Ballen, Philip C Amrein, Eyal C Attar, Julia Foster, Meghan Burke, Hector U Lopez, Christina R Matulis, Katherine M Edmonds, A John Iafrate, Kimberly S Straley, Katharine E Yen, Samuel Agresta, David P Schenkein, Cedric Hill, Ashkan Emadi, Donna S Neuberg, Richard M Stone, Yi-Bin Chen. Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. Blood. 2012 Nov; 120(23):4649-52. doi: 10.1182/blood-2012-06-438267. [PMID: 23074281]
  • D M Vail, B D Husbands, S G Kamerling, H Simpson, I D Kurzman, A McDonnell. Phase I study to determine the maximal tolerated dose and dose-limiting toxicities of orally administered idarubicin in dogs with lymphoma. Journal of veterinary internal medicine. 2012 May; 26(3):608-13. doi: 10.1111/j.1939-1676.2012.00896.x. [PMID: 22404399]
  • Saurabh Wadhwa, Russell J Mumper. Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy. Journal of controlled release : official journal of the Controlled Release Society. 2012 Mar; 158(2):215-23. doi: 10.1016/j.jconrel.2011.10.027. [PMID: 22063001]
  • Khairallah Alhareth, Christine Vauthier, Claire Gueutin, Gilles Ponchel, Fathi Moussa. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2012 Mar; 887-888(?):128-32. doi: 10.1016/j.jchromb.2012.01.025. [PMID: 22341684]
  • Lubica Roziakova, Eva Bojtarova, Martin Mistrik, Juraj Dubrava, Jozef Gergel, Nadezda Lenkova, Beata Mladosievicova. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. Journal of experimental & clinical cancer research : CR. 2012 Feb; 31(?):13. doi: 10.1186/1756-9966-31-13. [PMID: 22321767]
  • Yongzhong Wang, Li Chen, Yunfei Ding, Weili Yan. Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro. International journal of pharmaceutics. 2012 Jan; 422(1-2):409-17. doi: 10.1016/j.ijpharm.2011.10.029. [PMID: 22037443]
  • Pius S Fasinu, Patrick J Bouic, Bernd Rosenkranz. An overview of the evidence and mechanisms of herb-drug interactions. Frontiers in pharmacology. 2012; 3(?):69. doi: 10.3389/fphar.2012.00069. [PMID: 22557968]
  • Sang-Hun Kang, Soo-Jin Jeong, Sun-Hee Kim, Ji-Hyun Kim, Ji Hoon Jung, Wonil Koh, Jung Hyo Kim, Dae Keun Kim, Chang-Yan Chen, Sung-Hoon Kim. Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling. PloS one. 2012; 7(4):e28706. doi: 10.1371/journal.pone.0028706. [PMID: 22493659]
  • Puiyan Lee, Ruizhong Zhang, Vincent Li, Xuelai Liu, Raymond W Y Sun, Chi-Ming Che, Kenneth K Y Wong. Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation. International journal of nanomedicine. 2012; 7(?):731-7. doi: 10.2147/ijn.s28783. [PMID: 22359452]
  • Patrícia Severino, Tatiana Andreani, Ana Sofia Macedo, Joana F Fangueiro, Maria Helena A Santana, Amélia M Silva, Eliana B Souto. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. Journal of drug delivery. 2012; 2012(?):750891. doi: 10.1155/2012/750891. [PMID: 22175030]
  • Jozsef Karman, Nathan K Gumlaw, Jinhua Zhang, Ji-Lei Jiang, Seng H Cheng, Yunxiang Zhu. Proteasome inhibition is partially effective in attenuating pre-existing immunity against recombinant adeno-associated viral vectors. PloS one. 2012; 7(4):e34684. doi: 10.1371/journal.pone.0034684. [PMID: 22514654]
  • Kristof E Maudens, Christophe P Stove, Willy E Lambert. Quantitative liquid chromatographic analysis of anthracyclines in biological fluids. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2011 Sep; 879(25):2471-86. doi: 10.1016/j.jchromb.2011.07.010. [PMID: 21840776]
  • Wen Tan, Jinjian Lu, Mingqing Huang, Yingbo Li, Meiwan Chen, Guosheng Wu, Jian Gong, Zhangfeng Zhong, Zengtao Xu, Yuanye Dang, Jiajie Guo, Xiuping Chen, Yitao Wang. Anti-cancer natural products isolated from chinese medicinal herbs. Chinese medicine. 2011 Jul; 6(1):27. doi: 10.1186/1749-8546-6-27. [PMID: 21777476]
  • Yoshiki Tsuchiya, Yoshifumi Ubara, Tatsuya Suwabe, Junichi Hoshino, Keiichi Sumida, Rikako Hiramatsu, Eiko Hasegawa, Masayuki Yamanouchi, Noriko Hayami, Yuji Marui, Naoki Sawa, Fumi Takemoto, Kenmei Takaichi. Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis. Clinical and experimental nephrology. 2011 Jun; 15(3):434-437. doi: 10.1007/s10157-011-0405-5. [PMID: 21298312]
  • Wang Kai-Feng, Pan Hong-Ming, Lou Hai-Zhou, Shen Li-Rong, Zhu Xi-Yan. Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia. BMC cancer. 2011 May; 11(?):204. doi: 10.1186/1471-2407-11-204. [PMID: 21619578]
  • Roula A Farah, Khalil S Jalkh, Hussein Z Farhat, Paul E Sayad, Adel M Kadri. Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2011 Mar; 22(2):140-3. doi: 10.1097/mbc.0b013e32834248e6. [PMID: 21178585]
  • Kalpana Gupta, Amitabha Chakrabarti, Sonia Rana, Ritu Ramdeo, Bryan L Roth, Munna L Agarwal, William Tse, Mukesh K Agarwal, David N Wald. Securinine, a myeloid differentiation agent with therapeutic potential for AML. PloS one. 2011; 6(6):e21203. doi: 10.1371/journal.pone.0021203. [PMID: 21731671]
  • Mei-Ling Liu, Li-Yin Chien, Cheng-Jeng Tai, Kuan-Chia Lin, Chen-Jei Tai. Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients. Evidence-based complementary and alternative medicine : eCAM. 2011; 2011(?):291843. doi: 10.1093/ecam/nep185. [PMID: 19920087]
  • Anandamoy Rudra, R Manasa Deepa, Miltu Kumar Ghosh, Subhajit Ghosh, Biswajit Mukherjee. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. International journal of nanomedicine. 2010 Oct; 5(?):811-23. doi: 10.2147/ijn.s13031. [PMID: 21042545]
  • Ritesh Parajuli, Jessica Altman, Timothy Kuzel, Maria Perdekamp, Martin Tallman. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?. American journal of hematology. 2010 Oct; 85(10):829. doi: 10.1002/ajh.21813. [PMID: 20721888]
  • Cristina P Almeida, Carolina G Vital, Thais C Contente, Durvanei A Maria, Raul C Maranhão. Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake. International journal of nanomedicine. 2010 Sep; 5(?):679-86. doi: 10.2147/ijn.s12293. [PMID: 20957219]
  • Kostas Stylianou, Stavros Stratakis, Vasiliki Mavroeidi, Ioannis Petrakis, Dimitris Xydakis, Eleftheria Vardaki, Spyros Stratigis, Kostas Perakis, Theodora Katsarou, Peggy Kanellou, Irene Xylouri, Constantina Petraki, Michael Alexandrakis, Eugene Daphnis. Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report. Journal of medical case reports. 2010 Sep; 4(?):303. doi: 10.1186/1752-1947-4-303. [PMID: 20831803]
  • Jerzy Gubernator, Grzegorz Chwastek, Mariola Korycińska, Maria Stasiuk, Grzegorz Grynkiewicz, Felicitas Lewrick, Regine Süss, Arkadiusz Kozubek. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. Journal of controlled release : official journal of the Controlled Release Society. 2010 Aug; 146(1):68-75. doi: 10.1016/j.jconrel.2010.05.021. [PMID: 20510316]
  • Tapan M Kadia, Hui Yang, Alessandra Ferrajoli, Sirisha Maddipotti, Claudia Schroeder, Timothy L Madden, Julianne L Holleran, Merrill J Egorin, Farhad Ravandi, Deborah A Thomas, Willie Newsome, Blanca Sanchez-Gonzalez, James A Zwiebel, Igor Espinoza-Delgado, Hagop M Kantarjian, Guillermo Garcia-Manero. A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia. British journal of haematology. 2010 Jul; 150(1):72-82. doi: 10.1111/j.1365-2141.2010.08211.x. [PMID: 20456355]
  • Andrew S Holpuch, Garrett J Hummel, Meng Tong, Garrett A Seghi, Ping Pei, Ping Ma, Russell J Mumper, Susan R Mallery. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmaceutical research. 2010 Jul; 27(7):1224-36. doi: 10.1007/s11095-010-0121-y. [PMID: 20354767]
  • Farhad Ravandi, Jorge E Cortes, Daniel Jones, Stefan Faderl, Guillermo Garcia-Manero, Marina Y Konopleva, Susan O'Brien, Zeev Estrov, Gautam Borthakur, Deborah Thomas, Sherry R Pierce, Mark Brandt, Anna Byrd, B Nebiyou Bekele, Keith Pratz, Rajyalakshmi Luthra, Mark Levis, Michael Andreeff, Hagop M Kantarjian. Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Apr; 28(11):1856-62. doi: 10.1200/jco.2009.25.4888. [PMID: 20212254]
  • M Shokrzadeh, M Azadbakht, N Ahangar, H Naderi, S S Saeedi Saravi. Comparison of the cytotoxic effects of Juniperus sabina and Zataria multiflora extracts with Taxus baccata extract and Cisplatin on normal and cancer cell lines. Pharmacognosy magazine. 2010 Apr; 6(22):102-5. doi: 10.4103/0973-1296.62894. [PMID: 20668574]
  • Gülsüm Emel Pamuk, Murat Taşçi, Erman Oztürk, Muzaffer Demir. Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias. Medical oncology (Northwood, London, England). 2010 Mar; 27(1):16-9. doi: 10.1007/s12032-008-9163-y. [PMID: 19137431]
  • Daniel A Mulrooney, Mark W Yeazel, Toana Kawashima, Ann C Mertens, Pauline Mitby, Marilyn Stovall, Sarah S Donaldson, Daniel M Green, Charles A Sklar, Leslie L Robison, Wendy M Leisenring. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ (Clinical research ed.). 2009 Dec; 339(?):b4606. doi: 10.1136/bmj.b4606. [PMID: 19996459]
  • Farhat L Khanim, Rachel E Hayden, Jane Birtwistle, Alessia Lodi, Stefano Tiziani, Nicholas J Davies, Jon P Ride, Mark R Viant, Ulrich L Gunther, Joanne C Mountford, Heinrich Schrewe, Richard M Green, Jim A Murray, Mark T Drayson, Chris M Bunce. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. PloS one. 2009 Dec; 4(12):e8147. doi: 10.1371/journal.pone.0008147. [PMID: 19997560]
  • Kristof E Maudens, Christophe P Stove, Veronique F J Cocquyt, Hannelore Denys, Willy E Lambert. Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2009 Nov; 877(30):3907-15. doi: 10.1016/j.jchromb.2009.09.044. [PMID: 19828385]
  • Manthena V S Varma, Bo Feng, R Scott Obach, Matthew D Troutman, Jonathan Chupka, Howard R Miller, Ayman El-Kattan. Physicochemical determinants of human renal clearance. Journal of medicinal chemistry. 2009 Aug; 52(15):4844-52. doi: 10.1021/jm900403j. [PMID: 19445515]
  • Jianmin Wang, Shuqing Lü, Jianmin Yang, Xianmin Song, Li Chen, Chongmei Huang, Jun Hou, Weiping Zhang. A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China. Journal of hematology & oncology. 2009 Jul; 2(?):32. doi: 10.1186/1756-8722-2-32. [PMID: 19642997]
  • Thissiane L Gonçalves, Dalila M Benvegnú, Gabriela Bonfanti, Andressa V Frediani, João Batista T Rocha. Delta-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients. BMC cancer. 2009 May; 9(?):138. doi: 10.1186/1471-2407-9-138. [PMID: 19426494]
  • Ping Ma, Xiaowei Dong, Courtney L Swadley, Anshul Gupte, Markos Leggas, Harry C Ledebur, Russell J Mumper. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of biomedical nanotechnology. 2009 Apr; 5(2):151-61. doi: 10.1166/jbn.2009.1021. [PMID: 20055093]
  • Bradley A McGregor, Alexander W Brown, Michael B Osswald, Michael R Savona. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia. American journal of hematology. 2009 Apr; 84(4):228-30. doi: 10.1002/ajh.21365. [PMID: 19260120]
  • Tomoko Nanri, Eisaku Iwanaga, Satomi Fujie, Yasuhiro Yamada, Kentaro Horikawa, Hiroaki Mitsuya, Norio Asou. Micafungin-induced immune hemolysis attacks. International journal of hematology. 2009 Mar; 89(2):139-141. doi: 10.1007/s12185-008-0246-5. [PMID: 19148589]
  • J P M Derikx, N M A Blijlevens, J P Donnelly, H Fujii, T Kanda, A A van Bijnen, E Heineman, W A Buurman. Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Annals of oncology : official journal of the European Society for Medical Oncology. 2009 Feb; 20(2):337-42. doi: 10.1093/annonc/mdn579. [PMID: 18725393]
  • Agnieszka Marczak. Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde. Bioelectrochemistry (Amsterdam, Netherlands). 2009 Feb; 74(2):236-9. doi: 10.1016/j.bioelechem.2008.11.004. [PMID: 19064336]
  • Pau Montesinos, Juan M Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Angel León, Jordi Esteve, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, Miguel A Sanz. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009 Jan; 113(4):775-83. doi: 10.1182/blood-2008-07-168617. [PMID: 18945964]
  • Reyad Dada, Stefan Wilop, Edgar Jost, Oliver Galm, Nikolaus Gassler, Rainhardt Osieka. Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia. Acta haematologica. 2009; 122(4):216-20. doi: 10.1159/000253029. [PMID: 19887778]
  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • Patrick Shenjere, Ashok Roy, Brian Eyden, Saumitra S Banerjee. Pseudo-Gaucher cells in multiple myeloma. International journal of surgical pathology. 2008 Apr; 16(2):176-9. doi: 10.1177/1066896907311120. [PMID: 18417675]
  • Handan Ağirbasli, Hulya Bilgen, Sema Keceli Ozcan, Baris Otlu, Gulce Sinik, Nilgün Cerikçioğlu, Riza Durmaz, Emine Can, Nevin Yalman, Gunduz Gedikoğlu, Takashi Sugita. Two possible cases of Trichosporon infections in bone-marrow-transplanted children: the first case of T. japonicum isolated from clinical specimens. Japanese journal of infectious diseases. 2008 Mar; 61(2):130-2. doi: NULL. [PMID: 18362402]
  • Alessandra Tedeschi, Marco Montillo, Elena Strocchi, Anna Maria Cafro, Elisabetta Tresoldi, Liliana Intropido, Michele Nichelatti, Laura Marbello, Claudia Baratè, Carlo Maurizio Camaggi, Enrica Morra. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study. Cancer chemotherapy and pharmacology. 2007 May; 59(6):771-9. doi: 10.1007/s00280-006-0332-4. [PMID: 17256136]
  • Steven M Kornblau, Deborah E Banker, Derek Stirewalt, Danny Shen, Elizabeth Lemker, Srdan Verstovsek, Zeev Estrov, Stefan Faderl, Jorge Cortes, Miloslav Beran, C Ellen Jackson, Wenjing Chen, Elihu Estey, Frederick R Appelbaum. Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study. Blood. 2007 Apr; 109(7):2999-3006. doi: 10.1182/blood-2006-08-044446. [PMID: 17158228]
  • M Albitar, M Johnson, K A Do, A Day, I Jilani, S Pierce, E Estey, H Kantarjian, M Keating, S Verstovsek, S O'brien, F J Giles. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy. Leukemia. 2007 Mar; 21(3):480-8. doi: 10.1038/sj.leu.2404506. [PMID: 17215857]
  • Edit Bárdi, Ildikó Bobok, Anna V Oláh, János Kappelmayer, Csongor Kiss. Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathology oncology research : POR. 2007; 13(3):249-53. doi: 10.1007/bf02893506. [PMID: 17922055]
  • Miguel López-Lázaro, Nuria Pastor, Sami S Azrak, Maria Jesús Ayuso, Felipe Cortés, Caroline A Austin. Digitoxin, at concentrations commonly found in the plasma of cardiac patients, antagonizes etoposide and idarubicin activity in K562 leukemia cells. Leukemia research. 2006 Jul; 30(7):895-8. doi: 10.1016/j.leukres.2005.11.005. [PMID: 16387358]
  • D Crivellari, D Lombardi, G Corona, C Massacesi, R Talamini, R Sorio, M D Magri, C Lestuzzi, A Lucenti, A Veronesi, G Toffoli. Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring. Annals of oncology : official journal of the European Society for Medical Oncology. 2006 May; 17(5):807-12. doi: 10.1093/annonc/mdl013. [PMID: 16497825]
  • Agnieszka Marczak, Aleksandra Kowalczyk, Agata Wrzesień-Kus, Tadeusz Robak, Zofia Jóźwiak. Interaction of doxorubicin and idarubicin with red blood cells from acute myeloid leukaemia patients. Cell biology international. 2006 Feb; 30(2):127-32. doi: 10.1016/j.cellbi.2005.09.001. [PMID: 16271486]
  • Apichai Leelasiri, Tontanai Numbenjapol, Wichai Prayoonwiwat, Wichean Mongkolsritrakul, Chantrapa Srisawat. Successful treatment of retinoic acid syndrome with dexamethasone: a case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2005 Nov; 88 Suppl 3(?):S302-10. doi: NULL. [PMID: 16858973]
  • Ridvan Ali, Fahir Ozkalemkas, Vildan Ozkocaman, Tulay Ozcelik, Halis Akalin, Atilla Ozkan, Yildiz Altundal, Ahmet Tunali. Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis. Microbes and infection. 2005 Jul; 7(9-10):1073-6. doi: 10.1016/j.micinf.2005.02.015. [PMID: 15996888]
  • Ronit Regev, Daniella Yeheskely-Hayon, Hagar Katzir, Gera D Eytan. Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism. Biochemical pharmacology. 2005 Jul; 70(1):161-9. doi: 10.1016/j.bcp.2005.03.032. [PMID: 15919056]
  • Nancy Dos Santos, Dawn Waterhouse, Dana Masin, Paul G Tardi, Göran Karlsson, Katarina Edwards, Marcel B Bally. Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. Journal of controlled release : official journal of the Controlled Release Society. 2005 Jun; 105(1-2):89-105. doi: 10.1016/j.jconrel.2005.03.007. [PMID: 15878792]
  • N M A Blijlevens, J P Donnelly, B E de Pauw. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone marrow transplantation. 2005 Apr; 35(7):707-11. doi: 10.1038/sj.bmt.1704863. [PMID: 15785771]
  • J M Horácek, R Pudil, M Tichý, L Jebavý, A Strasová, R Praus, P Zák, J Malý. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. Neoplasma. 2005; 52(5):430-4. doi: NULL. [PMID: 16151589]
  • F Verholen, M Stalder, C Helg, Y Chalandon. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. European journal of haematology. 2004 Dec; 73(6):441-6. doi: 10.1111/j.1600-0609.2004.00320.x. [PMID: 15522068]
  • Joachim Drevs, Julia Fakler, Silke Eisele, Michael Medinger, Gerlinde Bing, Norbert Esser, Dieter Marmé, Clemens Unger. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer research. 2004 May; 24(3a):1759-63. doi: NULL. [PMID: 15274352]
  • R Morant, J Bernhard, D Dietrich, S Gillessen, M Bonomo, M Borner, J Bauer, T Cerny, C Rochlitz, M Wernli, A Gschwend, S Hanselmann, F Hering, H-P Schmid. Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial. British journal of cancer. 2004 Apr; 90(7):1312-7. doi: 10.1038/sj.bjc.6601673. [PMID: 15054447]
  • S Karakus, O Ozyilkan, Z Akçali, B Demirhan, M Haberal. Acute myeloid leukemia 4 years after Kaposi's sarcoma in a renal transplant recipient. Onkologie. 2004 Apr; 27(2):163-5. doi: 10.1159/000076906. [PMID: 15138349]
  • G Toffoli, R Sorio, B Basso, P Aita, G Corona, M Rupolo, G Ruolo, M Boiocchi. Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin. Journal of chemotherapy (Florence, Italy). 2004 Apr; 16(2):193-200. doi: 10.1179/joc.2004.16.2.193. [PMID: 15216956]
  • R J Veldman, S Zerp, W J van Blitterswijk, M Verheij. N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx. British journal of cancer. 2004 Feb; 90(4):917-25. doi: 10.1038/sj.bjc.6601581. [PMID: 14970874]
  • Cristina Sottani, Giovanna Tranfo, Maurizio Bettinelli, Paolo Faranda, Mariangela Spagnoli, Claudio Minoia. Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel. Rapid communications in mass spectrometry : RCM. 2004; 18(20):2426-36. doi: 10.1002/rcm.1642. [PMID: 15386628]
  • Frank Kroschinsky, Eberhard Schleyer, Ulf Renner, Claudia Schimming, Christoph Schimmelpfennig, Martin Bornhäuser, Thomas Illmer, Lorenz Trümper, Gerhard Ehninger, Markus Schaich. Increased myelotoxicity of idarubicin: is there a pharmacological basis? Results of a pharmacokinetic and an in vitro cytotoxicity study. Cancer chemotherapy and pharmacology. 2004 Jan; 53(1):61-7. doi: 10.1007/s00280-003-0700-2. [PMID: 12955471]
  • Jiroh Yamasaki, Tomoko Hata, Kengo Fuchigami, Katsuhiro Togami, Miyuki Honda, Takuya Fukushima, Yasushi Miyazaki, Itsuro Jinnai, Kazutaka Kuriyama, Masao Tomonaga. [Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2003 Oct; 44(10):1015-9. doi: NULL. [PMID: 14639948]
  • ZoAnn E Dreyer, Richard P Kadota, Clinton F Stewart, Henry S Friedman, Donald H Mahoney, Larry E Kun, Charles W McCluggage, Peter C Burger, James Kepner, Richard L Heideman. Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. Neuro-oncology. 2003 Oct; 5(4):261-7. doi: 10.1215/s115285170200056x. [PMID: 14565163]